|
Toll-like receptor 2 agonists as vaccine adjuvants
Toll-like receptor 2 agonists as vaccine adjuvants
Background
Vaccinations play an essential role in preventing infections in the population, reducing the number of deaths in vulnerable individuals, as well as preventing endemics of highly infectious diseases. Because of the protective nature of vaccinations, particularly for those in certain vulnerable...
Published: 3/24/2026
|
Updated: 5/31/2023
|
Inventor(s): Ofer Levy, David Dowling, Francesco Borriello, Spencer Brightman
Keywords(s): Adjuvants, Infectious Disease, Vaccine
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Vaccines, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Disease Area > Oncology
|
